The launch of Eli Lilly's weight-loss drug Zepbound is going swimmingly in the U.S., Jefferies said Friday.
Sima Sistani, WW International CEO, joins 'Closing Bell Overtime' to talk weight loss drugs, growth in WW's digital platforms and the stock's reaction.